| __timestamp | Amneal Pharmaceuticals, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 18516000 |
| Thursday, January 1, 2015 | 136870000 | 34140000 |
| Friday, January 1, 2016 | 204747000 | 51872000 |
| Sunday, January 1, 2017 | 191938000 | 71772000 |
| Monday, January 1, 2018 | 210451000 | 97501000 |
| Tuesday, January 1, 2019 | 202287000 | 118590000 |
| Wednesday, January 1, 2020 | 190585000 | 169802000 |
| Friday, January 1, 2021 | 209563000 | 192507000 |
| Saturday, January 1, 2022 | 200046000 | 199563000 |
| Sunday, January 1, 2023 | 167778000 | 253598000 |
Data in motion
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. Amneal Pharmaceuticals, Inc. and Xencor, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Amneal's R&D expenses have shown a steady trend, peaking in 2018 with a 97% increase from 2014. However, by 2023, their spending saw a decline of about 20% from its peak. In contrast, Xencor's R&D investment has surged dramatically, with a staggering 1,270% increase from 2014 to 2023. This growth highlights Xencor's commitment to innovation, culminating in 2023 when their R&D expenses surpassed Amneal's by 51%. This comparison underscores the dynamic strategies of these companies in the competitive pharmaceutical industry, where innovation is not just an option but a necessity.
Comparing Innovation Spending: Pfizer Inc. and Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
R&D Insights: How GSK plc and Xencor, Inc. Allocate Funds
Insmed Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Xencor, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Insights: How Amneal Pharmaceuticals, Inc. and Evotec SE Allocate Funds
Veracyte, Inc. vs Xencor, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: ACADIA Pharmaceuticals Inc. vs Xencor, Inc.
R&D Spending Showdown: Protagonist Therapeutics, Inc. vs Xencor, Inc.